CAN ONABOTULINUMTOXINA IMPROVE SYMPTOMS AND QUALITY OF LIFE IN ALL PATIENTS WITH OVERACTIVE BLADDER, REGARDLESS OF DISEASE DURATION OR BODY MASS INDEX?

被引：0
|
作者：
Chermansky, C. [1 ]
Rechberger, T. [2 ]
Miles-Thomas, J. [3 ]
Hale, D. [4 ]
Cardozo, L. [5 ]
Orejudos, A. [6 ]
Patel, A. [7 ]
Herschorn, S. [8 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
[2] Med Univ Lublin, Lublin, Poland
[3] Urol Virginia, Virginia Beach, VA USA
[4] Urogynecol Associates Pc, Indianapolis, IN USA
[5] Kings Coll Hosp London, London, England
[6] Allergan Plc, Irvine, CA USA
[7] Allergan Plc, Marlow, Bucks, England
[8] Univ Toronto, Toronto, ON, Canada
来源：
NEUROUROLOGY AND URODYNAMICS | 2018年 / 37卷
关键词：
PLACEBO-CONTROLLED TRIAL; URINARY-INCONTINENCE; DOUBLE-BLIND;
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
270
引用
收藏
页码：S219 / S220
页数：2
相关论文
共 50 条
  • [41] Prognostic importance of weight boss in patients coronary heart disease regardless of initial body mass index
    Sierra-Johnson, Justo
    Romero-Corral, Abel
    Somers, Virend K.
    Lopez-Jimenez, Francisco
    Thomas, Randal J.
    Squires, Ray W.
    Allison, Thomas G.
    EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2008, 15 (03): : 336 - 340
  • [42] THE PREVALENCE OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH MULTIPLE SCLEROSIS AND CORRELATIONS WITH INCREASED DISABILITY AS WELL AS REDUCED QUALITY OF LIFE
    Mahajan, Sangeeta
    Patel, Pragna
    Marrie, Ruth Ann
    JOURNAL OF UROLOGY, 2010, 183 (04): : E395 - E395
  • [43] THE PREVALENCE OF OVERACTIVE BLADDER SYMPTOMS IN PATIENTS WITH MULTIPLE SCLEROSIS: CORRELATIONS WITH INCREASED DISABILITY AS WELL AS REDUCED QUALITY OF LIFE
    Mahajan, Sangeeta
    Patel, Pragna
    Marrie, Ruth Ann
    NEUROUROLOGY AND URODYNAMICS, 2010, 29 (02) : 310 - 310
  • [44] Early and Consistent Improvements in Urinary Symptoms and Quality of Life With OnabotulinumtoxinA in Patients With Overactive Bladder and Urinary Incontinence: Results From a Randomized, Placebo-controlled, Phase IV Clinical Trial
    McCammon, Kurt
    Gousse, Angelo
    Kohan, Alfred
    Glazier, David
    Gruenenfelder, Jennifer
    Bai, Zhanying
    Patel, Anand
    Hale, Douglass
    FEMALE PELVIC MEDICINE AND RECONSTRUCTIVE SURGERY, 2021, 27 (07): : 450 - 456
  • [45] Comparison of weight-related symptoms and quality-of-life impacts by body mass index
    Bushnell, DM
    Martin, ML
    Patrick, DL
    VALUE IN HEALTH, 2003, 6 (03) : 325 - 325
  • [46] Influence of Body Mass Index and Duration of Disease on Chromosome Damage in Lymphocytes of Patients with Diabetes
    Siauliene, Laura
    Kazlauskaite, Jurate
    Jurkenaite, Dalia
    Visockiene, Zydrune
    Lazutka, Juozas R.
    LIFE-BASEL, 2023, 13 (09):
  • [47] Correlation between body mass index and overactive bladder symptoms in pre-menopausal women (vol 60, pg 111, 2014)
    Palma, Thais
    Raimondi, Marina
    Souto, Sophia
    Fozzatti, Celina
    Palma, Paulo
    Riccetto, Cassio
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2014, 60 (03): : 283 - 283
  • [48] Re: Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder Reply
    不详
    JOURNAL OF UROLOGY, 2018, 199 (03): : 857 - 858
  • [49] LONG-TERM EFFICACY, SAFETY, AND QUALITY OF LIFE ANALYSIS OF REPEATED ONABOTULINUMTOXINA TREATMENT FOR PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER SYNDROME AND URINARY INCONTINENCE
    Salvatore, Stefano
    Chapple, Christopher
    Sussman, David
    Radomski, Sidney
    Sand, Peter
    Guard, Steven
    Zhou, Jihao
    Sievert, Karl Dietrich
    Nitti, Victor
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 : S1 - S2
  • [50] Health-related quality of life and life satisfaction among female patients with gastrointestinal reflux disease (GERD) according to the Body Mass Index (BMI) and frequency of symptoms
    Schabowski, Janusz
    Gorczyca, Rafal
    Filip, Rafal
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2009, 11 (03): : 496 - 498
12345